In inflammatory diseases, CX3CL1 is released not only by the endothelium but also by monocytes, T lymphocytes, and NK cells as shown for rheumatoid arthritis and cardiovascular diseases [74] and further enhances the recruitment of inflammatory cells from the circulation. Here, CX3CL1 is linked to rheumatoid arthritis.